River Park Advisors, LLC Castle Biosciences Inc Transaction History
River Park Advisors, LLC
- $120 Million
- Q3 2024
A detailed history of River Park Advisors, LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, River Park Advisors, LLC holds 3,244 shares of CSTL stock, worth $98,131. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,244
Previous 3,136
3.44%
Holding current value
$98,131
Previous $68,000
35.29%
% of portfolio
0.08%
Previous 0.06%
Shares
4 transactions
Others Institutions Holding CSTL
# of Institutions
201Shares Held
24.5MCall Options Held
303KPut Options Held
30.3K-
Black Rock Inc. New York, NY3.04MShares$92.1 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.83MShares$55.2 Million0.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.75MShares$52.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.26MShares$38.2 Million0.61% of portfolio
-
Portolan Capital Management, LLC Boston, MA1.26MShares$38 Million2.85% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $795M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...